Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ShareHope Medicine CoROCO:8403 68 5-Year Yield-on-Cost % is 2.60 as of Aug. 15, 2026, which is 65% above its 10-year median of 1.58. GuruFocus rates ROCO:8403 with a GF Score™ of 68/100 and a GF Value™ of NT$29.91 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 69 Medical Distribution companies, ShareHope Medicine Co ranks worse than 65.22% on this metric.
ShareHope Medicine Co's yield on cost for the quarter that ended in Mar. 2026 was 2.60.
The historical rank and industry rank for ShareHope Medicine Co's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:8403'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.99 Med: 1.58 Max: 4.4
Current: 2.6
During the past 13 years, ShareHope Medicine Co's highest Yield on Cost was 4.40. The lowest was 0.99. And the median was 1.58.
ROCO:8403's 5-Year Yield-on-Cost % is ranked worse than 65.22% of 69
companies
in the Medical Distribution industry
Industry Median: 3.14
vs ROCO:8403: 2.60
ShareHope Medicine Co (ROCO:8403) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
ShareHope Medicine Co 5-Year Yield-on-Cost % Related Terms
ROCO:8403 vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, ShareHope Medicine Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ShareHope Medicine Co 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ShareHope Medicine Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where ShareHope Medicine Co's 5-Year Yield-on-Cost % falls into.
ShareHope Medicine Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
ShareHope Medicine Co (ROCO:8403) has a 5-Year Yield-on-Cost % of 2.60 as of Aug. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on ShareHope Medicine Co and its competitors. This is 65% above median its historical median of 1.58. Over the past decade, ShareHope Medicine Co's 5-Year Yield-on-Cost % has ranged from 0.99 to 4.40. According to the industry distribution chart, ShareHope Medicine Co ranks #45 out of 69 companies in the Medical Distribution industry, placing it in the top 65.2%.
Is ShareHope Medicine Co's 5-Year Yield-on-Cost % too high?
ShareHope Medicine Co's current 5-Year Yield-on-Cost % of 2.60 is 65% above median its 10-year median of 1.58. Over the past 10 years, this metric has ranged from a low of 0.99 to a high of 4.40. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.14. ShareHope Medicine Co's value of 2.60 is 17.2% below this industry median. Based on the distribution chart, ShareHope Medicine Co ranks #45 out of 69 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, ShareHope Medicine Co has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ShareHope Medicine Co's 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ShareHope Medicine Co ranks #45 out of 69 companies for 5-Year Yield-on-Cost %. This places ShareHope Medicine Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.14. ShareHope Medicine Co's value of 2.60 is 17.2% below this benchmark. Historically, ShareHope Medicine Co's own 5-Year Yield-on-Cost % has ranged from 0.99 to 4.40 over the past decade. While the company's 10-year median is 1.58 vs. the industry median of 3.14, ShareHope Medicine Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.14, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ShareHope Medicine Co's current 5-Year Yield-on-Cost % of 2.60 is 17.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on ShareHope Medicine Co and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ShareHope Medicine Co's current 5-Year Yield-on-Cost % is 2.60, which is 65% above median its own 10-year median of 1.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ShareHope Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, ShareHope Medicine Co (ROCO:8403) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.91, compared to a current price of NT$19.20 — trading 35.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 2.60, which is 65% above median its 10-year median of 1.58 and 17.2% below the Medical Distribution industry median of 3.14. ShareHope Medicine Co's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For ShareHope Medicine Co (ROCO:8403), the current 5-Year Yield-on-Cost % is 2.60 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ShareHope Medicine Co (ROCO:8403) Overvalued in 2026?
Based on GuruFocus' analysis, ShareHope Medicine Co stock appears to be undervalued.
The current stock price of NT$19.20 is trading 35.8% below its estimated GF Value™ of NT$29.91.
GuruFocus considers ShareHope Medicine Co to be Possible Value Trap.
Key valuation signals for ROCO:8403:
5-Year Yield-on-Cost %: 2.60 (65% above median its 10-year median of 1.58)
GF Value™: NT$29.91 vs. price of NT$19.20 (35.8% below fair value)
Industry Position: 17.2% below the Medical Distribution median (#45 of 69)
No single metric tells the full story. See the ROCO:8403 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ShareHope Medicine Co Ltd is engaged in wholesale and retail sales of medicines and hygiene materials, leasing of assets for medical institutions to undertake related medical services, and physical examinations for Taiwanese people and foreign labors, on-site medical support services, hemodialysis business management, ophthalmic medical management, clothing-related management services, manufacturing, processing and sales of various non-woven fabrics and management consulting for chain pharmacies in collaboration with medical institutions.
68GF Score
Get the complete analysis for ROCO:8403
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8403 has been successfully added to your 
